Trial Profile
A First in human clinical study of OraPro-COVID-19
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2021
Price :
$35
*
At a glance
- Drugs COVID-19 vaccine Stabilitech Biopharma (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; First in man
- 30 Sep 2020 According to an iosBio media release, the company expect to initiate this trial in Q1 2021.
- 24 Mar 2020 New trial record
- 19 Mar 2020 According to a Stabilitech Biopharma media release, the company plans to initiate this study within weeks.